| Net income | -31.35M |
| Depreciation and amortization | |
| Intangible asset impairment | |
| Contingent consideration write-off | |
| Charges for inventory obsolescence and valuation adjustments | |
| Restricted stock compensation | |
| Deferred taxes | |
| Other noncash items | |
| Trade accounts receivable | |
| Inventories | |
| Prepaid expenses and other assets | |
| Current income taxes | |
| Accounts payable | |
| Accrued expenses | |
| Net cash provided by operating activities | -317K |
| Additions to property, plant and equipment | -7.67M |
| Other, net | |
| Net cash used by investing activities | -7.64M |
| Principal payments on long-term debt and notes payable | -12.11M |
| Advances on revolving line of credit | |
| Payments on revolving line of credit | |
| Changes in outstanding checks in excess of bank deposits | |
| Other, net | |
| Net cash (used) provided by financing activities | -740K |
| Net increase in cash and cash equivalents | -8.7M |
| Cash and cash equivalents, beginning of year | 10.5M |
| Cash and cash equivalents, end of quarter | 1.8M |